Phosphate buffered ophthalmic solutions displaying improved efficacy

Details for Australian Patent Application No. 2009226112 (hide)

Owner Johnson & Johnson Vision Care, Inc.

Inventors McKee, Robert T.; Collins, Gary L.; Lada, Mark; Hargiss, Marcie

Agent Callinan

Pub. Number AU-A-2009226112

PCT Pub. Number WO2009/117056

Priority 12/399,681 06.03.09 US; 61/037,894 19.03.08 US

Filing date 9 March 2009

Wipo publication date 24 September 2009

International Classifications

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 33/40 (2006.01) Medicinal preparations containing inorganic active ingredients - Peroxides

A61K 47/02 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Inorganic compounds

A61L 12/12 (2006.01) Methods or apparatus for disinfecting or sterilising contact lenses

Event Publications

16 September 2010 PCT application entered the National Phase

  PCT publication WO2009/117056 Priority application(s): WO2009/117056

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009226113-Ophthalmic solutions displaying improved efficacy

2009226106-Use of tea-derived, theaflavin enriched extract to increase exercise performance and reduce exercise recovery time